Research
Hormonal
Saturated fatty acids activate Toll-like receptors (TLR2 and TLR4) on immune and adipose cells, triggering proinflammatory cytokine production (TNF-α, IL-6) and contributing to insulin resistance, whereas unsaturated fatty acids inhibit this signaling.
Dietary fat quality matters for inflammation. Saturated fats can trigger immune receptors (TLRs) that promote inflammation and insulin resistance, while unsaturated fats (like those in fish oil) can block this pathway. Prioritize unsaturated fats to mitigate inflammatory signaling.
ModerateSupportsHIGH confidence
saturated fatty acids were able to induce the activation of TLR2 and TLR4, whereas unsaturated fatty acids inhibited TLR-mediated signaling pathways and gene expression... Nutritional saturated fatty acids potently stimulated IL-6 or tumour necrosis factor (TNF)-α mRNA expression in macrophage-like cells, whereas food-derived polyunsaturated fatty acids had no effect alone but inhibited saturated fatty acid-induced TNF-α mRNA expression.
Why this rating
The paper is a review citing multiple in vitro and animal studies; human data is mentioned but less detailed than mechanistic pathways.
Source
Feeding Our Immune System: Impact on Metabolism
Isabelle Wolowczuk et al. · Clinical and Developmental Immunology · 2008
DOI 10.1155/2008/639803
narrative_reviewCited 297×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Glucose is the primary fuel source for immune cells, with activation leading to a rapid increase in glucose consumption and glycolysis, similar to insulin-responsive adipose tissue.Good
- TLR4 deficiency protects mice from diet-induced obesity and improves insulin sensitivity, although effects on body weight are contradictory across studies.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →